A two years extension to a one year multicenter, partially blinded double dummy randomized study to evaluate the efficacy and safety of FTY720 combined with reduced dose or full dose Neoral and corticosteroids vs mycophenolate mofetil combined with full dose Neoral and corticosteroids in de novo adult renal transplant recipients
Active, not recruiting
- Conditions
- Prevention of the acute rejection in renal transplant patientMedDRA version: 6.1Level: PTClassification code 10023439
- Registration Number
- EUCTR2004-004958-63-IT
- Lead Sponsor
- OVARTIS FARMA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Recruiting
- Sex
- All
- Target Recruitment
- 600
Inclusion Criteria
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: ;Secondary Objective: ;Primary end point(s):
- Secondary Outcome Measures
Name Time Method